Literature DB >> 26291399

Selection of the upper vertebra to be instrumented in the treatment of thoracolumbar and lumbar adolescent idiopathic scoliosis by anterior correction and fusion surgery using dual-rod instrumentation: a minimum 12-year follow-up study.

Hideki Sudo1, Kiyoshi Kaneda2, Yasuhiro Shono3, Norimasa Iwasaki4.   

Abstract

BACKGROUND CONTEXT: Consensus regarding the optimal upper vertebra to be instrumented during surgical treatment of Lenke 5C thoracolumbar and lumbar adolescent idiopathic scoliosis (AIS) remains limited.
PURPOSE: This study aimed to assess whether a short fusion strategy is appropriate for correction of a Lenke 5C AIS curve by anterior correction and fusion surgery using dual-rod instrumentation. STUDY
DESIGN: This study design used retrospective comparative analysis of a prospectively collected, consecutive, non-randomized series of patients at a single institution. PATIENT SAMPLE: Thirty consecutive patients with Lenke 5C AIS treated with anterior correction and fusion surgery using dual-rod instrumentation were included. OUTCOME MEASURES: Patient demographics, radiographic measurements, and Scoliosis Research Society-22 questionnaire (SRS-22) scores were the outcome measures for this study.
METHODS: Thirty patients were treated surgically for AIS with a Lenke 5C curve (mean age, 14.4 years [11-19 years)]) and followed up for a mean period of 17.2 years (12-23 years). Radiographical parameters and clinical outcomes were compared between patients treatment with the end vertebra (EV) instrumented (n=14) and those treated by short fusion (S group) with instrumentation starting at the vertebra one level caudal to the EV (n=16 patients). There were no study-specific biases related to conflicts of interest.
RESULTS: In the EV group, a mean preoperative Cobb angle of 56° was corrected to 5° after surgery and to 8° at the final follow-up. In the S group, a mean preoperative Cobb angle of 55° was corrected to 10° after surgery and 14° at the final follow-up. The mean correction rate at the final follow-up was significantly lower in the S group (74%) than in the EV group (86%; p=.020). The coronal and sagittal balance, thoracic kyphosis, lumbar lordosis, and clinical outcomes evaluated using SRS-22 did not differ between the two groups.
CONCLUSIONS: The short fusion strategy, which involves instrumentation of the vertebra one level caudal to the upper EV, can be considered as an alternative to the conventional strategy, which includes instrumentation of the upper EV, for treating Lenke 5C curves via anterior spinal fusion.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescent idiopathic scoliosis; Anterior spinal fusion; Comparison study; Lenke 5C scoliosis; Short fusion; Upper instrumented vertebra

Mesh:

Year:  2015        PMID: 26291399     DOI: 10.1016/j.spinee.2015.08.021

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  4 in total

1.  Optimizing the fusion level for lenke 5C adolescent idiopathic scoliosis: is the S-line a validated and reproducible tool to predict coronal decompensation?

Authors:  Tianyuan Zhang; Shibin Shu; Wenting Jing; Qi Gu; Zezhang Zhu; Zhen Liu; Yong Qiu; Xu Sun; Bin Wang; Hongda Bao
Journal:  Eur Spine J       Date:  2021-03-04       Impact factor: 3.134

2.  Anterior versus posterior approach in Lenke 5C adolescent idiopathic scoliosis: a meta-analysis of fusion segments and radiological outcomes.

Authors:  Ming Luo; Wengang Wang; Mingkui Shen; Lei Xia
Journal:  J Orthop Surg Res       Date:  2016-07-11       Impact factor: 2.359

Review 3.  Decision Making Algorithm for Adult Spinal Deformity Surgery.

Authors:  Yongjung J Kim; Seung-Jae Hyun; Gene Cheh; Samuel K Cho; Seung-Chul Rhim
Journal:  J Korean Neurosurg Soc       Date:  2016-07-08

4.  Reducing the kyphosis effect of anterior short thoracolumbar/lumbar scoliosis correction with an autograft fulcrum effect.

Authors:  Mazda Farshad; Andrea Frey; Thorsten Jentzsch; Michael Betz; Jonas Widmer; José Miguel Spirig
Journal:  BMC Musculoskelet Disord       Date:  2021-02-23       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.